ResMed Inc (STU:RME)
€ 232.3 -1.9 (-0.81%) Market Cap: 34.52 Bil Enterprise Value: 34.92 Bil PE Ratio: 32.70 PB Ratio: 6.98 GF Score: 98/100

Resmed Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 09:30PM GMT
Release Date Price: €180 (+0.56%)
David A. Low
JPMorgan Chase & Co, Research Division - Research Analyst

Hello, everyone. My name is David Low. I cover health care stocks for JPMorgan in Australia. With us today, we have the CEO of ResMed, Mick Farrell. Mick is going to give us roughly a 20-minute presentation, and that will be followed by Q&A session with Mick and his team. As you'd all know, you can lodge a question with the Ask A Question function in the digital conference book.

So with that, I'll hand over to you, Mick. Thanks.

Michael J. Farrell
ResMed Inc. - CEO & Director

Fantastic. Thanks, David, for the very efficient introduction there. Look forward to our Q&A in a little moment here. Since everybody has their digital power deck, I'll just -- PowerPoint deck, I'll just call out the slides as we go through.

First page is just an introduction. I've got old school hard copy here. Second page is all the legal disclaimers, feel free to read through those there or on our website. Third page is our company overview and strategy. So I'm on the fourth page

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot